[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-05", "acceptance_datetime": "2025-11-05T21:14:36Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-266967", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-266967/files/tyra-20250930_htm.xml", "financials": {"balance_sheet": {"current_assets": {"value": 281216000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 21342000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 1991000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 301851000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 5463000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 301851000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 1346000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 13888000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 20635000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 280509000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 19289000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 15879000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 280509000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -29868000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 59670757.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 32944000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -29868000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 7475000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 59670757.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -29868000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 25469000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -29868000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -32944000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -29868000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.5, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.5, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": 3076000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -22380000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 647000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -14806000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -36539000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -14806000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -22380000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -36539000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 647000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -29862000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -29862000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -29862000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-14", "acceptance_datetime": "2025-08-14T20:17:47Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-108899", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-108899/files/tyra-20250630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 583000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -23680000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -2231000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -2231000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 20866000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 20866000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 583000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -23680000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"liabilities": {"value": 19352000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 302147000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 19344000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 302155000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 13770000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 321499000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 321499000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 302147000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1413000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 11525000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 17931000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 2245000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -28098000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -28350000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -28098000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -31452000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 31452000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 24309000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -28098000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 3354000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_average_shares": {"value": 59550771.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.47, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -28098000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 7143000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -28098000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.47, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 59550771.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -28098000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T20:10:01Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066942", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066942/files/tyra-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 2187000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 32026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 32026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -25458000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -25458000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 2187000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 8755000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 8755000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -28229000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -28147000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 11746000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 19942000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 343476000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 323534000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 14246000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 323534000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 1522000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 18910000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 343476000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 324566000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 2500000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 17388000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -28147000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -28147000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.47, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.47, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 6886000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -28147000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 24964000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -28147000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 59336550.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 59336550.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": 3703000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -28147000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 31850000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -31850000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 706000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -19590000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -11926000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -11926000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 6958000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -19590000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 6958000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 706000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -25571000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -25571000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 618696, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 29744000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.42999999999999994, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 4173000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -25571000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 7564000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -29744000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -25571000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 618696, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -25571000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 22180000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_earnings_per_share": {"value": -0.42999999999999994, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -26553000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -26553000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -26553000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"current_liabilities": {"value": 14594000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 14004000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 343151000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 363558000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 1651000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 343151000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 16095000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 347463000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 363558000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 5813000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 14444000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 590000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 20407000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-07", "acceptance_datetime": "2024-11-07T21:13:07Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-123346", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-123346/files/tyra-20240930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 4402000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 21557000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -17898000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 4402000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 743000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -17898000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 743000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 21557000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -22080000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -22080000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -22080000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -24016000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -24016000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": 4588000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 58874497.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -28604000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 28604000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 5907000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 58874497.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -24016000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -24016000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -24016000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 22697000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"noncurrent_liabilities": {"value": 5931000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 12373000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 362288000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 18304000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 1165000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 11208000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 13192000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 380592000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 380592000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 14981000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 365611000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 362288000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 1789000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-07", "acceptance_datetime": "2024-08-07T20:10:15Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-092778", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-092778/files/tyra-20240630_htm.xml", "financials": {"balance_sheet": {"other_noncurrent_assets": {"value": 11989000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 392461000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 13887000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 10382000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 378574000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 8805000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 376043000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 16418000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 1898000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 392461000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 1577000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 376043000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -10258000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -154876000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -144991000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -144991000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -10258000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -154876000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 373000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 373000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -18702000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": 4830000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -18702000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -18702000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 17997000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_average_shares": {"value": 58668712.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 5535000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 23532000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -18702000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -18702000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -23532000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 58668712.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -18702000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -18880000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T20:12:29Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-056971", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-056971/files/tyra-20240331_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 8716000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 13963000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 1593000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 12370000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 389879000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 5837000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 390778000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 2879000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 404741000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 389879000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 14862000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 404741000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -18192000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -18192000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -18192000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -18192000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 52228934.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 17203000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -18192000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 52228934.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -22322000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": 4130000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 5119000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 22322000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 18073000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -22028000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 196360000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 18073000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 200315000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 196360000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -22028000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 200315000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -18192000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -18579000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -22449000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -68753000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -22449000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"current_liabilities": {"value": 15333000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 225857000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 21595000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 12558000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 204262000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 225857000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 4662000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 10671000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 211671000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 6262000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1628000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 14186000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 204262000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -22830000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.53, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 25634000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 4957000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 85801, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -22830000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": 2804000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_average_shares": {"value": 85801, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 20677000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.53, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -22830000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -25634000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -22830000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -22830000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -13532000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -157646000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -144438000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -157646000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -144438000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 324000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -13532000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 324000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-07", "acceptance_datetime": "2023-11-07T21:16:24Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-060276", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-060276/files/tyra-20230930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -83000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 467000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 467000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -16761000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -83000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -16761000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -17145000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -17145000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"basic_earnings_per_share": {"value": -0.49, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 2811000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -21152000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -21152000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -21152000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.49, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 4692000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "selling_general_and_administrative_expenses": {"value": 0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 42868340.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_average_shares": {"value": 42868340.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -21152000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -21152000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -23963000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 23963000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 19271000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -21152000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -21152000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"assets": {"value": 238358000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 16188000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 2308000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 7839000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 222170000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 13728000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 12581000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 10147000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 222170000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 6041000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 224630000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 1147000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 238358000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-10", "acceptance_datetime": "2023-08-10T20:27:15Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-041382", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-041382/files/tyra-20230630_htm.xml", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -0.31, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": 2742000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "selling_general_and_administrative_expenses": {"value": 0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_average_shares": {"value": 42589213.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -13272000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -13272000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -13272000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 16014000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 42589213.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.31, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 12162000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -16014000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 3852000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -13272000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -13272000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "balance_sheet": {"other_noncurrent_assets": {"value": 8212000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 3965000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 1440000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 238572000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 238572000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 11440000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 250012000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 5405000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 250012000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 240746000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 9266000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 1054000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -9615000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -43000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -9288000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 370000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 370000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -9615000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -43000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -9288000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -13272000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -13272000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-04", "acceptance_datetime": "2023-05-04T20:16:08Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-017875", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-017875/files/tyra-20230331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -11880000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -11880000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"research_and_development": {"value": 10408000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -14334000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -11880000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -11880000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 42394623.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -11880000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 3926000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "selling_general_and_administrative_expenses": {"value": 0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": -11880000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 42394623.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": 2454000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -11880000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 14334000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -41000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -41000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -9847000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 376000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -9847000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 376000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -9512000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -9512000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"assets": {"value": 255055000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 1280000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 2402000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 248790000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1048000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 248790000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 6265000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 8346000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 3682000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 7298000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 255055000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 246709000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 3000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -21000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 3000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -21000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -11998000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -11998000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -11980000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -11980000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"other_current_liabilities": {"value": 4556000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 8352000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 257829000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 266181000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 257288000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 8893000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 2651000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 7816000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 257829000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 266181000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 1077000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 1145000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 5701000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -12895000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -12895000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -12895000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -15018000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 4618000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.30000000000000004, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 106852, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "diluted_earnings_per_share": {"value": -0.30000000000000004, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": 2123000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 15018000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -12895000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 106852, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -12895000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 10400000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -12893000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12895000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-021937", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-021937/files/tyra-20220930_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 267756000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 2747000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 2742000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 8514000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 267756000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 275985000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 8229000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 2740000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 275985000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 1146000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 267471000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 7368000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 5489000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -12509000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -12509000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 41997195.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 2730000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 41997195.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -13645000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -12509000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12509000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": 1136000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -12509000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 13645000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 10915000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -12509000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -12509000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -11896000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 364000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -48000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -48000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 364000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -12212000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -11896000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -12212000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014802", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014802/files/tyra-20220630_htm.xml", "financials": {"balance_sheet": {"other_current_liabilities": {"value": 3112000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 9819000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 2343000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 277299000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 8265000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 287118000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 278853000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1201000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 287118000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 278853000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 8618000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 5455000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"research_and_development": {"value": 12047000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 15428000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -15095000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 41777206.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15095000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 3381000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 41777206.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -15095000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -15428000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -15095000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -15095000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 333000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -15095000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -15095000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 27000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 27000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -17392000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -17168000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -17168000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -251000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -17392000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -251000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "acceptance_datetime": "2022-05-05T20:32:35Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-007879", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-007879/files/tyra-20220331_htm.xml", "financials": {"balance_sheet": {"fixed_assets": {"value": 1008000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 1356000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 294025000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 4946000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 4901000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 291184000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 3938000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 291184000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 3545000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 7787000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 298971000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 298971000.0, "unit": "USD", "label": "Assets", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -14826000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -14826000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 238000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -8925000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -8926000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -239000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 238000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -8926000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -239000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -8925000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"diluted_average_shares": {"value": -112051, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": -112051, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 14834000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -14826000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -14834000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -14826000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 9645000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -14826000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14826000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 5189000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": 8000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -14826000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -9930000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -9930000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -9930000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -9930000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -9932000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -9930000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -9929000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 2000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 7250000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 2682000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 9932000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -9930000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": -1508000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -1508000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -9028000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -9028000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -105000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -10641000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -10641000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -105000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"current_liabilities": {"value": 3616000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1348000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 306701000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 306701000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 301737000.0, "unit": "USD", "label": "Equity", "order": 1400}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "liabilities": {"value": 4964000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 2644000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_assets": {"value": 304057000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 599000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 3017000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 301737000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 1027000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 1617000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-002837", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-002837/files/tyra-20210930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -6643000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -6643000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"research_and_development": {"value": 5484000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -6643000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 1154000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 6638000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -6643000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 10621868.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": -5000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -6643000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -6643000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -6643000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -6638000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "balance_sheet": {"temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 315970000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 1690000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 6239000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 309731000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 315970000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 313501000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "accounts_payable": {"value": 2068000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 779000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 2469000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 4768000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 309731000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 2700000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 1471000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2021-03-31", "end_date": "2021-06-30", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"balance_sheet": {"liabilities": {"value": 22667000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -22667000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 22667000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -22667000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -5512000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -5512000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -5512000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -5512000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -5512000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -5512000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -5512000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-30", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001863127", "sic": "2834", "tickers": ["TYRA"], "company_name": "Tyra Biosciences, Inc.", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -4209000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -4209000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -4209000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -4209000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -4209000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -17522000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -17522000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 17522000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 17522000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -4209000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -4209000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}]